This cost-plus-fixed-fee contract with mapp biopharmaceutical, INC. (mapp or contractor) is for the development of mapp?S therapeutic intervention MBP091, as an immunotherapy for the treatment of…
Active Definitive Contract Awarded Last action
- Contract number
- 75A50122C00076
- Awardee
-
Mapp Biopharmaceutical, Inc. UEI M9V9QTHR1H28
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $155,212,688
Award facts
- Opportunity
-
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Pre-Solicitation · BAA18100SOL00003 · Posted Oct 16, 2017
- Contract value 52% obligated
-
- $155,212,688.03 Current, with exercised options
- $299,926,734.03 Potential, with all options
- Completion date 30% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $44,335,303 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $12,563,458 | |
| Supplemental Agreement for work within scope | $19,833,117 | |
| Other Administrative Action | $0 | |
| Original award | $78,480,810 |
Show all 18
About this award
The Office of the Assistant Secretary for Preparedness and Response awarded a definitive cost-plus-fixed-fee contract to Mapp Biopharmaceutical, Inc. for development of MBP091, a therapeutic immunotherapy for Marburg virus infection, with a ceiling value of $299.9 million and an ultimate completion date of July 31, 2036. The award exercises option 1 and updates the statement of work; the initial award date was July 23, 2021, with this action dated September 28, 2022.
Place of performance is San Diego, CA. The originating solicitation was a Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement posted October 16, 2017, seeking advanced research and development of medical countermeasures against chemical, biological, radiological, and nuclear threats, with multiple awards anticipated in the $750,000 to $8 million range depending on project scope.
In FY2024, the contract generated $20.4 million in invoiced labor across 9.9 FTEs and 20,587 contractor hours, reflecting a derived government-paid hourly rate of $992.60 per hour. Mapp engaged 12 subcontractors during the same period. The derived hourly rate rose from $296.75 per hour in FY2022 (7 contractor hours invoiced), indicating an escalation in labor intensity and cost profile as development progressed toward clinical advancement.
Description
This cost-plus-fixed-fee contract with mapp biopharmaceutical, INC. (mapp or contractor) is for the development of mapp?S therapeutic intervention MBP091, as an immunotherapy for the treatment of marburg virus infection.
Quick answers
Who was awarded contract 75A50122C00076?
75A50122C00076 was awarded to Mapp Biopharmaceutical, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 28, 2022.
How much is contract 75A50122C00076 worth?
The government has obligated $155,212,688 on 75A50122C00076. Its potential value, with all options, is $299,926,734.
Was contract 75A50122C00076 competed?
The extent of competition for 75A50122C00076 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award